1. Home
  2. DCBO vs KMDA Comparison

DCBO vs KMDA Comparison

Compare DCBO & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Docebo Inc.

DCBO

Docebo Inc.

HOLD

Current Price

$16.22

Market Cap

489.9M

Sector

N/A

ML Signal

HOLD

Logo Kamada Ltd.

KMDA

Kamada Ltd.

HOLD

Current Price

$8.40

Market Cap

488.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DCBO
KMDA
Founded
2016
1990
Country
Canada
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
489.9M
488.6M
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
DCBO
KMDA
Price
$16.22
$8.40
Analyst Decision
Buy
Strong Buy
Analyst Count
9
2
Target Price
$32.00
$14.00
AVG Volume (30 Days)
100.6K
56.4K
Earning Date
05-08-2026
05-13-2026
Dividend Yield
N/A
2.97%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$12.89
$13.94
Revenue Next Year
$11.44
$9.84
P/E Ratio
$22.04
$24.59
Revenue Growth
N/A
N/A
52 Week Low
$14.39
$6.35
52 Week High
$33.69
$9.35

Technical Indicators

Market Signals
Indicator
DCBO
KMDA
Relative Strength Index (RSI) 41.90 47.88
Support Level N/A $8.38
Resistance Level $20.15 $8.88
Average True Range (ATR) 0.84 0.19
MACD -0.17 0.02
Stochastic Oscillator 42.96 68.25

Price Performance

Historical Comparison
DCBO
KMDA

About DCBO Docebo Inc.

Docebo Inc is a provider of cloud-based learning management systems. The solutions provided by the company allow learning administrators to deliver scalable and flexible personalized learning experiences, from formal training to social learning to multiple internal, external, and blended audiences. The group provides an easy-to-use, configurable, and affordable learning platform with the end-to-end capabilities and critical functionality needed to train both internal and external workforces, partners, and customers. The majority of the revenue is derived from customers based in North America.

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Share on Social Networks: